Sector portfolio · Private equity · Hong Kong SAR China

CDH Investments' Biotech portfolio

CDH Investments has backed 23 Biotech startups in rounds we track, $2.0B between them, shown by the stage each has reached. The best-funded is Brainco.

23startups backed
4stages
$2.0Braised between them
Series C and laterbiggest stage

CDH Investments's whole portfolioCDH Investments's profile

Segment by segment

Series C and later

7 startups · $838M raised

  1. II-MabChina$220M
  2. CBCreative BiosciencesCreative Biosciences is a biomedical technology company.China$132M
  3. Cloudbreak TherapeuticsCloudbreak Therapeutics is a clinical stage biotechnology companyUnited States$130M
  4. Virogin BiotechVirogin Biotech is a clinical-stage immuno-oncology company based in Richmond/Vancouver, British Columbia, Canada.Canada$120M
  5. ATAusperBio TherapeuticsUnited States$120M
  6. GenFleet TherapeuticsGenFleet Therapeutics is a biotechnology developer and researcher of molecular pharmaceuticals targeting cancer treatments.China$96M
  7. Qitan TechnologyQitan Technology is a Developer of a genome sequencing technology.China$20M

Stage not reported

6 startups · $617M raised

  1. BrainCoBrain Co.United States$292M
  2. MedbanksMedbanks develops customized medical service and health care based on self-built medical expert network and drugstore network, proChina$201M
  3. Soyoung新氧 soyoung is an internet company based out of China.China$60M
  4. HitGenHitGen is provides biological reagents and services to support drug discovery research.China$39M
  5. HemaCellHemaCell is a new cell therapy company to regenerate hematopoietic lineages in vitro, with unique stem cell reprogramming.China$17M
  6. RootPathRootPath is a synthetic biology company dedicated to reducing the cost of gene synthesis and enhancing gene function interrogation.United States$8.4M

Series A

6 startups · $119M raised

  1. Spear BioSpear Bio is a biotechnology startup based in Woburn, Massachusetts, founded in 2021.United States$45M
  2. GemPharmatechGemPharmatech Co., Ltd.United States$23M
  3. MMengmeiMengmei is a medical service organization founded by 6 doctors of American Dream Beauty HRC.China$15M
  4. Innolake BiopharmInnolake Biopharm is a clinical stage biotech company, dedicated to developing innovative medicines against cancer and autoimmune China$14M
  5. Ceram PharmaceuticalsCeram Pharmaceuticals is a biotech firm that uses epigenetics to carry out R&D of drugs and diagnostic treatments for cancer and diseases.China$14M
  6. UniXell BiotechnologyUniXell Biotechnology is a new-generation cell therapy drug developer, focuses on the development of a new generation of cell therapy drugs.China$7.2M

Series B

4 startups · $418M raised

  1. Harbour BioMedHarbour BioMed is a clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology.China$190M
  2. AusperBioAusperBio is a clinical-stage biopharmaceutical company dedicated to advancing treatments for hepatitis B virus (HBV) and developiUnited States$113M
  3. Singleron BiotechnologiesSingleron Biotechnologies is an innovative molecular diagnostic company.China$100M
  4. Daxiang BiotechDaxiang Biotech is a biotechnology innovator focused on organoid, organ-on-a-chip, and microphysiological system technologies for China$15M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names CDH Investments as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios

Raising from investors like CDH Investments?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.